<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Pharmacology - INI CET NOVEMBER 2022 (PART - B)</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Pharmacology - INI CET NOVEMBER 2022 (PART - B)</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                22 Questions | 22 Total Marks | 32 min Duration | ~87.27 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 22 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 32 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 22</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Pharmacology - INI CET NOVEMBER 2022 (PART - B) - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 22</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 22 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "Which of the following drugs acts by increasing trabecular outflow?", "options": [{"label": "A", "text": "Netarsudil", "correct": true}, {"label": "B", "text": "Acetazolamide", "correct": false}, {"label": "C", "text": "Brimonidine", "correct": false}, {"label": "D", "text": "Timolol", "correct": false}], "correct_answer": "A. Netarsudil", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Netarsudil Among the options, Netarsudil is the drug which increases the trabecular meshwork outflow.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Netarsudil is an ocular hypotensive agent, which inhibits Rho kinase and norepinephrine transport resulting in relaxation of the trabecular meshwork. It appears to reduce IOP by increasing outflow of aqueous humour through the trabecular meshwork and decreasing episcleral venous pressure via its inhibitory effect on rho kinases. It is used in the treatment and management of glaucoma and ocular hypotension . Administered topically Conjunctival hyperemia, corneal verticillata, pain are  the common side effects with the drug Timolol - nonselective beta blocker - decreases IOP by reducing the production of aqueous humour from ciliary epithelium Brimonidine - selective alpha 2 agonist - it decreases aqueous secretions and increases uveoscleral outflow Acetazolamide -  carbonic anhydrase inhibitor - Decrease IOP by reducing the synthesis of aqueous humour</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Dose-response curves of 3 drugs are given. Pick the right statement", "options": [{"label": "A", "text": "C is a non-competitive antagonist", "correct": false}, {"label": "B", "text": "A and B are agonist", "correct": true}, {"label": "C", "text": "A is more efficacious than B", "correct": false}, {"label": "D", "text": "B is more potent than A", "correct": false}], "correct_answer": "B. A and B are agonist", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1691671939694-QTDJPYQ025IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>A and B are agonist</p>\n<p><strong>Highyeild:</strong></p><p>An agonist is a drug that binds to the receptor, producing a similar response to the intended chemical and receptor. Whereas an antagonist is a drug that binds to the receptor either on the primary site, or on another site, which all together stops the receptor from producing a response . Partial agonists have a lower intrinsic activity at receptors than full agonists. In the presence of a full agonist, partial agonists behave like a competitive antagonist. Potency denotes the amount of drug needed to produce a given effect. Efficacy : Refers to the relative ability of a drug-receptor complex to produce a maximum functional response .</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- In the given image A and B are agonists and C is a partial agonist. Both the drug A and B have similar efficacy as they produce the same maximal response. Drug A is more potent than B because A produces the same effect at a lower dose.</p>\n<p><strong>Table:</strong></p><p>#MANTRA</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A hypertensive patient with K+ 6.5 meq/I, Na+ 137 meq/I, urea 42, creatinine 3.8. Which of the following drugs should be stopped?", "options": [{"label": "A", "text": "Furosemide", "correct": false}, {"label": "B", "text": "Metoprolol", "correct": false}, {"label": "C", "text": "Losartan", "correct": true}, {"label": "D", "text": "Amlodipine", "correct": false}], "correct_answer": "C. Losartan", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Losartan Losartan is a medicine used to treat high blood pressure and heart disease. Lowering blood pressure helps to prevent future heart attack and stroke. This medicine is also effective in preserving kidney function in patients with diabetes.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A. Furosemide belongs to a group of medicines called diuretics or water tablets. It is used to reduce the swelling (edema) caused by too much water in the body in people who have heart failure, liver or kidney disease. This medicine is also used to treat high blood pressure. Option B. Metoprolol is a selective Î²1 receptor blocker medication. It is used to treat high blood pressure, chest pain due to poor blood flow to the heart, and a number of conditions involving an abnormally fast heart rate. By working on the beta-1 receptor Option D. Amlodipine is a medicine used to treat high blood pressure (hypertension) and to prevent angina (heart-related chest pain). It is known as a calcium channel blocker and helps to lower blood pressure and reduce the workload of the heart. This helps prevent heart attacks and strokes.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Antihypertensive Agents 1 ACE inhibitors (Angiotensin converting enzyme inhibitors) Enalapril, Lisinopril, Ramipril, Captopril 2 ARBS (Angiotensin receptor blockers) Telmisartan, Olmesartan, Losartan, Candesartan, Valsartan 3 Calcium channel blockers Amlodipine, Felodipine, Nimodipine, Nifedipine, Isradipine, Verapamil, Diltiazem 4 Beta blockers Atenolol, Metoprolol, Bisoprolol, Labetolol, Propranolol, 5 Diuretics Hydrochlorthiazide, Chlorthiazide, Chlorthalidone, Spironolactone, Furosemide 6 Direct Vasodilators Hydralazine, Minoxidil, Sodium Nitropruside, Diazoxide 7 Alpha blockers Terazosin, Doxazosin, Prazosin 8 Central Alpha 2 Agonists Clonidine, Methyldopa</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Finasteride used to treat male pattern baldness acts by inhibiting which of the following enzyme?", "options": [{"label": "A", "text": "Aromatase", "correct": false}, {"label": "B", "text": "5-Alpha Reductase", "correct": true}, {"label": "C", "text": "17-hydrolase", "correct": false}, {"label": "D", "text": "Phosphodiesterase", "correct": false}], "correct_answer": "B. 5-Alpha Reductase", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>5-Alpha Reductase Finasteride is used to treat male pattern baldness by inhibiting 5-alpha reductase. Finasteride is a competitive inhibitor of 5-alpha reductase which inhibits the conversion of testosterone to its active form, dihydrotestosterone (DHT), within the hair follicles. Hence it is used in the treatment of male pattern baldness.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A. Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and in men, and gynecomastia in men. They may also be used off-label to reduce estrogen conversion when supplementing testosterone exogenously. Option C . 17-hydrolase The most common abnormal alleles of this condition impair both the 17Î±-hydroxylase activity and the 17,20-lyase activity of CYP17A1. Like other forms of CAH, 17Î±-hydroxylase deficiency impairs the efficiency of cortisol synthesis, resulting in high levels of ACTH secretion and hyperplasia of the adrenal glands. Option D . Phosphodiesterase- A phosphodiesterase inhibitor is a drug that blocks one or more of the five subtypes of the enzyme phosphodiesterase (PDE), thereby preventing the inactivation of the intracellular second messengers, cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) by the respective PDE subtype(s).</p>\n<p><strong>Table:</strong></p><p>#MANTRA alpha- reductase inhibitor 5 Another approach to blocking androgen uptake by prostatic cells is to prevent androgen binding to nuclear androgen receptors (e.g. Flutamide). There are also anti-androgens that block both LH and nuclear androgen uptake. In BPH patients, this has been demonstrated to improve flow rates & voiding symptoms. Indication: Prostate size > 40 gm IS/E include impotence, decreased libido & lowers serum PSA by approximately 50% within 6 months of use.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Urinary alkalinisation will be most useful in which of the following toxicities?", "options": [{"label": "A", "text": "Beta blockers", "correct": false}, {"label": "B", "text": "Calcium channel blockers", "correct": false}, {"label": "C", "text": "Aspirin", "correct": true}, {"label": "D", "text": "Acetaminophen", "correct": false}], "correct_answer": "C. Aspirin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Aspirin Aspirin is an antiplatelet medicine used to treat and prevent heart attacks, strokes, and heart-related chest pain (angina). It helps to prevent the formation of blood clots in your blood vessels. It is a very widely used medicine for heart protection.</p>\n<p><strong>Highyeild:</strong></p><p>Alkalinisation of urine will be useful for the removal of aspirin, which is a weakly acidic drug, and gets excreted in urine. Urinary excretion of an acidic drug can be increased by the alkalinisation of urine, whereas a basic drug can be increasingly excreted in the urine by acidification of urine. Non Ionised compounds are reabsorbed more rapidly than ionised polar molecules. Alkalinisation of the urine by IV sodium bicarbonate ionisation of aspirin molecules increases. Consequently, their reabsorption is decreased and hence excreted more effectively.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A. Beta blockers- Beta blockers are competitive antagonists that block the receptor sites for the endogenous catecholamines epinephrine (adrenaline) and norepinephrine (noradrenaline) on adrenergic beta receptors, of the sympathetic nervous system, which mediates the fight-or-flight response Option B. Calcium channel blockers prevent calcium from entering cells of the heart and blood vessel walls, resulting in lower blood pressure. Calcium channel blockers, also called calcium antagonists, relax and widen blood vessels by affecting the muscle cells in the arterial walls. Option D. Paracetamol is a widely prescribed medicine that helps to ease pain and bring down high body temperature (fever). In children, it treats conditions like headache, toothache, body ache, fever, and common cold.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Aspirin Used for relief, particularly where there is inflammation involved, such as arthritic pain and dental pain. Also used in preventing blood clotting and relieving fever. Active ingredient: acetylsalicylic acid Acidic in nature. Side effects: â†’  Can cause bleeding in the stomach as aspirin is very acidic. â†’  Can cause allergic reactions, skin rashes and asthmatic attacks. â†’ Can cause brain & liver damage to chlidren with flu / chicken pox. (Never be given to children) â†’ Can cause ulcers & internal bleeding.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Sildenafil acts by?", "options": [{"label": "A", "text": "Phosphodiesterase 5 inhibition", "correct": true}, {"label": "B", "text": "IP3 pathway", "correct": false}, {"label": "C", "text": "Nitric oxide and cyclic GMP", "correct": false}, {"label": "D", "text": "Cyclic AMP", "correct": false}], "correct_answer": "A. Phosphodiesterase 5 inhibition", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Phosphodiesterase 5 inhibition A phosphodiesterase type 5 inhibitor (PDE5 inhibitor) is a vasodilating drug that works by blocking the degradative action of cGMP-specific phosphodiesterase type 5 (PDE5) on cyclic GMP in the smooth muscle cells lining the blood vessels supplying various tissues. These drugs dilate the corpora cavernosa of the penis,</p>\n<p><strong>Highyeild:</strong></p><p>Sildenafil acts by phosphodiesterase 5 inhibition and is used in the treatment of erectile dysfunction. PDE-5 inhibitors cause the accumulation of cGMP in the corpus cavernosum, which causes relaxation of penile artery smooth muscles which fills the corpora cavernosum and improves erectile dysfunction. Sildenafil is also used in the treatment of pulmonary artery hypertension.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option B . The IP3 signaling pathway is well mapped out, and is known to be important in regulating a variety of calcium-dependent cell signaling pathways. Signaling pathway [ edit] PLC cleavage of PIP 2 to IP 3 and DAG initiates intracellular calcium release and PKC activation Option C. Nitric oxide and cyclic GMP Endothelium-dependent vasodilators or nitrovasodilators produce nitric oxide, which activates soluble guanylyl cyclase to form cyclic GMP (cGMP). cGMP activates cGMP-dependent protein kinase, resulting in protein phosphorylation, decreased cytosolic calcium levels, myosin light chain dephosphorylation, and relaxation. Option D. Cyclic AMP is a second messenger, or cellular signal occurring within cells, that is important in many biological processes. cAMP is a derivative of adenosine triphosphate (ATP) and used for intracellular signal transduction in many different organisms, conveying the cAMP-dependent pathway.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Match the mechanism of action of antiarrhythmic drugs", "options": [{"label": "A", "text": "A-2, B-1, C-3, D-4", "correct": false}, {"label": "B", "text": "A-4, B-3, C-2, D-1", "correct": false}, {"label": "C", "text": "A-3, B-4, C-1, D-4", "correct": false}, {"label": "D", "text": "A-4, B-3, C-1, D-2", "correct": true}], "correct_answer": "D. A-4, B-3, C-1, D-2", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1691671940007-QTDJPYQ030IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>A-4, B-3, C-1, D-2</p>\n<p><strong>Highyeild:</strong></p><p>Digoxin is a Na/K ATPase inhibitor , increases AV node refractoriness Ibutilide is a class III antiarrhythmic agent, which blocks K channels Esmolol is a beta blocker, belongs to class II antiarrhythmics Quinidine is a Na channel blocker, belongs to class IA antiarrhythmics</p>\n<p><strong>Random:</strong></p><p>Explanation for All options:- Option A. Digoxin is a medicine used for the treatment of heart failure in combination with other medicines. It helps to provide symptomatic relief by making the heart pump blood more efficiently. This medicine is also used to treat abnormal heart rhythm (arrhythmia). Option B. Ibutilide is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset to sinus rhythm. It exerts its antiarrhythmic effect by induction of slow inward sodium current, which prolongs action potential and refractory period Option C. Esmolol belongs to a group of medicines called beta-blockers. It is used to treat emergency high blood pressure (hypertension), angina (heart-related chest pain), irregular heart rhythms (arrhythmia). Option D. Quinidine is a class IA antiarrhythmic agent used to treat heart rhythm disturbances. It is a diastereomer of antimalarial agent quinine, originally derived from the bark of the cinchona tree. The drug causes increased action potential duration, as well as a prolonged QT interval</p>\n<p><strong>Table:</strong></p><p>#MANTRA Classification of Anti-Arrhythmic Drugs (Vaughan-Williams-Singh..1969) Class I: block Na* channels la (quinidine, procainamide, disopyramide) (1-10s) lb (lignocaine) (<1s) Ic (flecainide) (>10s) Class II: B-adrenoceptor antagonists (atenolol, sotalol) Class III: prolong action potential and prolong refractory period (amiodarone, dofetilide, sotalol) Class IV: Ca2+ channel antagonists (verapamil, diltiazem)</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which among the following are agonists at Î²2 receptors? Dipivefrine Dopexamine Mirabegron Fenoldopam Select the correct answer from the given code below.", "options": [{"label": "A", "text": "1,2 and 3", "correct": false}, {"label": "B", "text": "1,3 and 4", "correct": false}, {"label": "C", "text": "1 and 2", "correct": true}, {"label": "D", "text": "3 and 4", "correct": false}], "correct_answer": "C. 1 and 2", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>1 and 2 Dipivefrine and dopexamine are beta-2 adrenergic receptor agonists.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Dipivefrine causes a decrease in aqueous production and increases outflow. It is used in the treatment of open-angle glaucoma. Dopexamine is a synthetic dopamine analogue which acts at D1, D2 and beta-2 receptors. It is used in severe congestive heart failure, sepsis and shock. Fenoldopam is a peripheral D1 agonist with some activity at alpha-2 adrenergic receptors. Used as vasodilator in severe hypertension Mirabegron is a beta-3 receptor agonist used for urinary bladder incontinence.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Beta-2 receptor actions Organ Action Result Bronchus Relaxation Bronchodilation Uterus Relaxation Uterus relaxes Skeletal muscle BVS Relaxation Vasodilation â†’ Increased blood flow Liver Glycogenolysis Increased blood glucose</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "New drug application is filed after which phase of clinical trials:", "options": [{"label": "A", "text": "1", "correct": false}, {"label": "B", "text": "2", "correct": false}, {"label": "C", "text": "3", "correct": true}, {"label": "D", "text": "4", "correct": false}], "correct_answer": "C. 3", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>3 New drug application is filed after phase 3 of clinical trials.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Phase 1 trials are done in healthy volunteers to assess the drug effect in humans Phase 2 is the first round of trials in patients to evaluate safety and benefit Phase 3 is done to confirm the safety and efficacy. New drug application is filed after this phase Phase 4 is the post-marketing surveillance.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient who is a known addict is brought to the hospital with intoxication of an agent. Ocular examination shows the following. Which of the following is true regarding this condition?", "options": [{"label": "A", "text": "This action can be reversed by phenylephrine", "correct": false}, {"label": "B", "text": "Cannot be reversed by levallorphan", "correct": false}, {"label": "C", "text": "Caused due to activation of Edinger Westphal nucleus", "correct": true}, {"label": "D", "text": "Tolerance develops due to long term use", "correct": false}], "correct_answer": "C. Caused due to activation of Edinger Westphal nucleus", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1691671940089-QTDJPYQ033IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Caused due to activation of Edinger Westphal nucleus The image shows a pinpoint pupil (miosis). Along with the clinical scenario, it is suggestive of opioid overdose. It is caused due to activation of the Edinger Westphal nucleus.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A. Phenylephrine is an alpha-selective agonist which causes mydriasis. But it is not useful in the reversal of opioid-induced miosis. Option B. Levallorphan is an opioid antagonist used in opioid overdose. It reverses the effects of opioid overdose. Option D. Tolerance to miosis does not develop due to long term opioid use.</p>\n<p><strong>Table:</strong></p><p>#MANTRA</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which among the following is the false statement regarding statins?", "options": [{"label": "A", "text": "Although HMG CoA reductase inhibitors substantially reduce the risk of cardiovascular events, there is mild increase in lipoprotein a (Lpa) levels", "correct": false}, {"label": "B", "text": "These drugs should not be stopped even in severe conditions like injury, surgery, etc.", "correct": false}, {"label": "C", "text": "It can be given with verapamil and other enzyme inhibitors", "correct": true}, {"label": "D", "text": "With the long term use there is slight increase in the incidence of type 2 diabetes mellitus", "correct": false}], "correct_answer": "C. It can be given with verapamil and other enzyme inhibitors", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>It can be given with verapamil and other enzyme inhibitors Statins like atorvastatin and rosuvastatin are metabolised by cytochrome 3A4 enzymes of the liver. Verapamil is a cytochrome 3A4 inhibitor and interferes with the metabolism of statins. Increased serum statin levels may cause myopathy in the form of myalgia and rhabdomyolysis.</p>\n<p><strong>Highyeild:</strong></p><p>Statins are hypolipidemic drugs which act by inhibiting HMG-CoA reductase enzyme involved in cholesterol synthesis. Statins lower serum LDL and triglycerides and increase HDL levels. Although HMG CoA reductase inhibitors substantially reduce the risk of cardiovascular events, there is mild increase in lipoprotein a (Lpa) levels Statins are continued during surgery and injury. They reduce overall mortality due to cardiovascular events and inflammatory responses. With the long term use there is slight increase in the incidence of type 2 diabetes mellitus</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Rest optionâ€™s are not associated with statins.</p>\n<p><strong>Table:</strong></p><p>#MANTRA High-, Moderate-, and Low-Intensity Statin Therapy High-Intensity Moderate-Intensity Low-Intensity Lowers LDL-C by â‰¥50% Lowers LDL-C by 30-49% Lowers LDL-C by <30% Atorvastatin 40-80 mg Rosuvastatin 20-40 mg Atorvastatin 10-20 mg Rosuvastatin 5-10 mg Simvastatin 20-40 mg Pravastatin 40-80 mg Lovastatin 40-80 mg Fluvastatin XL 80 mg Fluvastatin 40 mg bid Pitavastatin 1-4 mg Simvastatin 10 mg Pravastatin 10-20 mg Lovastatin 20 mg Fluvastatin 20-40 mg</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "An antiarrhythmic drug is shown to have the following effect. It is effective both in atrial and ventricular arrhythmias. Identify the drug.", "options": [{"label": "A", "text": "Quinidine", "correct": true}, {"label": "B", "text": "Tocainide", "correct": false}, {"label": "C", "text": "Propranolol", "correct": false}, {"label": "D", "text": "Lignocaine", "correct": false}], "correct_answer": "A. Quinidine", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1691671940492-QTDJPYQ035IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Quinidine Quinidine is a class IA antiarrhythmic agent. It has sodium blocking and significant potassium channel blocking properties. It prolongs QRS duration and action potential duration.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option C. Propranolol is a beta blocker.Propranolol belongs to a group of medicines called beta-blockers. It helps to decrease anxiety and relieve tremors. It is also used to help prevent migraine, heart-related chest pain (angina), and bleeding in the stomach caused by high blood pressure in the liver (portal hypertension). Option D. Lignocaine and tocainide reduces phase 4 slope</p>\n<p><strong>Table:</strong></p><p>#MANTRA Classification of Anti-Arrhythmic Drugs (Vaughan-Williams-Singh 1969) Class I: block Na* channels la (quinidine, procainamide, disopyramide) (1-10s) lb (lignocaine) (<1s) Ic (flecainide) (>10s) Class II: B-adrenoceptor antagonists (atenolol, sotalol) Class III: prolong action potential and prolong refractory period (amiodarone, dofetilide, sotalol) Class IV: Ca2+ channel antagonists (verapamil, diltiazem)</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A hospital is conducting a study to check the efficacy of statins in multiple centres. There are 4-5 patients and half of them receive the drug and half a placebo. Neither the patients nor clinicians know who got what. This is best described as", "options": [{"label": "A", "text": "Phase 1", "correct": false}, {"label": "B", "text": "Phase 2", "correct": false}, {"label": "C", "text": "Phase 4", "correct": false}, {"label": "D", "text": "Phase 3", "correct": true}], "correct_answer": "D. Phase 3", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Phase 3 A hospital conducting a double-blinded multicentric study to check the efficacy of statins describe the phase 3 of clinical trials.</p>\n<p><strong>Highyeild:</strong></p><p>Clinical study design phases Phase 1 Drug action, metabolism, PK, PD, safety Phase 2 Limited (un)controlled study for efficacy and safety Phase 3 Large randomized multicenter study Determine efficacy and safety for FDA and EMEA Phase 4 After drug release: new uses of the drug Marketing</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Phase 1 studies the pharmacokinetics and tolerability in humans Phase 2 is done to evaluate the drug efficacy and dosage Phase 4 is the post marketing surveillance</p>\n<p><strong>Table:</strong></p><p>#MANTRA Stage of Development Phase 1 Phase 2 Phase 3 Phase 4 End Point Safety Efficacy Efficacy Efficacy Specific End Point Safety Profile Cardiac Output Reduction in Mortality Rate Reduction in Mortality Rate Types of Studies Different Indications; Single or Multiple Dose Placebo Controlled; Dose Escalation Placebo Controlled; Long Term Follow Up Comparative; New Indications</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Rituximab is ___ among the following", "options": [{"label": "A", "text": "Monoclonal antibody which acts against CD20", "correct": true}, {"label": "B", "text": "Polyclonal antibody which acts against CD20", "correct": false}, {"label": "C", "text": "Monoclonal antibody which acts against CD52", "correct": false}, {"label": "D", "text": "Polyclonal antibody which acts against CD52", "correct": false}], "correct_answer": "A. Monoclonal antibody which acts against CD20", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Monoclonal antibody which acts against CD20</p>\n<p><strong>Highyeild:</strong></p><p>Rituximab is a monoclonal antibody that targets CD20 B-cell antigen . It induces apoptosis through transmembrane signalling, antibody-dependent , and complement-dependent cytotoxicity . It